SEBI Cracks Down on Seven Entities for Social Media Stock Manipulation Freezes 20 Crore Gains Amazon UK Chief Highlights Education Systems Role in Youth Unemployment China Confirms Order for 200 Boeing Jets Signaling Renewed Aviation Cooperation with US AI Drug Discovery Advances May Reshape Treatment Landscape for Brain Conditions Flex Expands Partnership with Teradyne Robotics to Accelerate Intelligent Automation in Manufacturing Amazon Named Top Internet Sector Pick by Wolfe Research SIGIP Q1 2026 Earnings Preferred Stock EPS Misses Estimate Shares Edge Lower GBank Financial Holdings Inc GBFH Q1 2026 Earnings Significant EPS Miss as Earnings Fall Short of Expectations Sunoco Q1 2026 Earnings Massive EPS Beat Highlights Operational Strength SBGI Q1 2026 Earnings Strong EPS Surprise Amid a Shifting Media Landscape LNZA Q4 2025 Earnings Loss Narrower Than Expected Shares Slide T1 Energy Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Absence Foxx Development Holdings FOXX Plunges Nearly 16 as Selling Pressure Intensifies Vertex Inc VERX Rallies 2 as Stock Approaches Key Resistance Zone Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Market Awaits Catalysts SR Bancorp SRBK Surges Over 2 as Bulls Test Key Resistance at 1964 Riverview Bancorp RVSB Slides 211 as Support Level Tested Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility BLX Q1 2026 Earnings Earnings Per Share Reported at 131 Shares Dip 227 Enovix Corporation ENVX Surges on Renewed Buying Interest Key Levels in Focus Halozyme Stays Above Support After Minor Decline Key Levels to Watch Krispy Kreme DNUT Slips 18 to 327 as Stock Tests Key Support Zone Melco Resorts Entertainment MLCO Edges Lower Amid Cautious Trading Xperi Inc XPER Edges Higher A Cautious Recovery from Support Levels Circle Internet Group CRCL Surges 55 as Bullish Momentum Builds Nektar Therapeutics NKTR Holds Steady Near Support as Biotech Sector Awaits Catalysts Apollomics Inc Warrant APLMW Holds Steady Near Minimal Levels A Closer Look at the Biotech Derivative